BUY Union Bank of India — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·21 Jul · today
Broker’s Call: Union Bank of India (Add)
NewsHbl·16 Jul · 5d ago
Union Bank of India announced its financial results for the quarter ended June 30, 2026. The press release includes key highlights such as net profit, interest income, business growth, deposit growth,
NSE · Press Release·15 Jul · 6d ago
Union Bank of India has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·15 Jul · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Union Bank of India
- BUY — Aditya Agarwal, Coheron Brokers22 Oct 2026 · ~2 weeks · target ₹195 · Active
- BUY — Sumeet Bagadia, Choice Broking22 Oct 2026 · ~2 weeks · target ₹192 · Active
- BUY — Vikas Sethi, Sethi Finmart22 Oct 2026 · Same day · target ₹186 · Expired
- BUY — Amit Seth22 Oct 2026 · ~2 weeks · target ₹190 · Active
- BUY — Manas Jaiswal21 Oct 2026 · Same day · target ₹188 · Expired
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

